BEVACIZUMAB-AWWB

BEVACIZUMAB-AWWB was reported 4692 times

BEVACIZUMAB-AWWB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTED TOMOGRAPHIC ABSCESSOGRAM 1 1.0000
1 HYDRAEMIA 1 0.1667
2 CHEST TUBE REMOVAL 1 0.0909
3 CULTURE URINE 1 0.0909
4 BACTERIAL ENDOPHTHALMITIS 23 0.0865
5 LATEROPULSION 1 0.0833
6 NEUROVASCULAR CONFLICT 1 0.0625
7 NEUROLOGICAL EXAMINATION 1 0.0556
8 REACTIVE PERFORATING COLLAGENOSIS 2 0.0541
9 LACTOBACILLUS BACTERAEMIA 1 0.0476
10 BILE DUCT STENT REMOVAL 1 0.0370
11 BIOPSY STOMACH 1 0.0357
12 ASTROVIRUS TEST POSITIVE 1 0.0333
13 BETA-2 GLYCOPROTEIN ANTIBODY POSITIVE 1 0.0323
14 HEREDITARY HAEMORRHAGIC TELANGIECTASIA 3 0.0306
15 GLIOSARCOMA 1 0.0286
16 LIVER ABLATION 2 0.0263
17 CARCINOEMBRYONIC ANTIGEN DECREASED 1 0.0238
18 RECTAL CANCER RECURRENT 2 0.0235
19 MAGNETIC RESONANCE IMAGING 3 0.0233
20 OCCUPATIONAL EXPOSURE TO AIR CONTAMINANTS 1 0.0227
21 LABORATORY TEST 3 0.0222
22 ANAL CANCER METASTATIC 1 0.0217
23 LARYNGEAL PAPILLOMA 1 0.0213
24 RECTAL CANCER METASTATIC 6 0.0172
25 CYTOREDUCTIVE SURGERY 1 0.0161
26 HOME CARE 1 0.0156
27 BILIARY CATHETER INSERTION 1 0.0149
28 INTERVENTIONAL PROCEDURE 1 0.0135
29 BRAIN RADIATION NECROSIS 1 0.0135
30 ABDOMINAL WALL WOUND 2 0.0130
31 INTERCEPTED PRODUCT ADMINISTRATION ERROR 98 0.0128
32 OVERFLOW DIARRHOEA 1 0.0125
33 PRODUCT SUBSTITUTION 5 0.0124
34 MALIGNANT GASTROINTESTINAL OBSTRUCTION 1 0.0119
35 DILATED PORES 1 0.0110
36 ELECTIVE SURGERY 2 0.0109
37 GASTROINTESTINAL ULCER PERFORATION 1 0.0108
38 OVARIAN EPITHELIAL CANCER 2 0.0105
39 CARDIORENAL SYNDROME 6 0.0105
40 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 346 0.0102
41 IMAGING PROCEDURE ABNORMAL 1 0.0100
42 HAEMOGLOBIN URINE PRESENT 2 0.0099
43 LIPOSARCOMA 3 0.0094
44 AGE-RELATED MACULAR DEGENERATION 14 0.0092
45 FAILURE TO ANASTOMOSE 1 0.0091
46 GLIOBLASTOMA 15 0.0088
47 OBSTRUCTIVE NEPHROPATHY 1 0.0081
48 INTERCEPTED PRODUCT SELECTION ERROR 10 0.0077
49 REFUSAL OF TREATMENT BY PATIENT 50 0.0076
50 PROTEIN URINE PRESENT 38 0.0076
51 OSTEOMYELITIS ACUTE 4 0.0074
52 ABDOMINAL WOUND DEHISCENCE 2 0.0073
53 BILOMA 1 0.0071
54 PARALYSIS RECURRENT LARYNGEAL NERVE 1 0.0068
55 DECEREBRATE POSTURE 1 0.0068
56 OESOPHAGOBRONCHIAL FISTULA 1 0.0066
57 DRUG THERAPEUTIC INCOMPATIBILITY 1 0.0065
58 BIOPSY 6 0.0065
59 PNEUMONIA CHLAMYDIAL 1 0.0064
60 ENDOPHTHALMITIS 38 0.0063
61 COLORECTAL CANCER METASTATIC 15 0.0063
62 TUMOUR PERFORATION 2 0.0063
63 ADENOCARCINOMA OF THE CERVIX 1 0.0062
64 PAIN MANAGEMENT 1 0.0059
65 OCCUPATIONAL EXPOSURE TO PRODUCT 38 0.0059
66 PH URINE INCREASED 1 0.0058
67 RADIOTHERAPY 11 0.0057
68 CERVIX CARCINOMA RECURRENT 1 0.0056
69 PROTEIN URINE 5 0.0055
70 DENTAL CARE 10 0.0054
71 BLOOD TEST 1 0.0053
72 BILE DUCT STENT INSERTION 2 0.0052
73 CHOROIDAL HAEMORRHAGE 1 0.0052
74 CEREBELLAR STROKE 2 0.0051
75 TOXIC NEUROPATHY 2 0.0051
76 ASTROCYTOMA 2 0.0051
77 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 7 0.0050
78 PRODUCT STORAGE ERROR 437 0.0050
79 GENITAL ABSCESS 2 0.0050
80 ADENOCARCINOMA METASTATIC 1 0.0049
81 MUSCLE ABSCESS 3 0.0048
82 ADENOCARCINOMA OF COLON 9 0.0048
83 CATHETER SITE INJURY 1 0.0047
84 INTERCEPTED PRODUCT PREPARATION ERROR 54 0.0044
85 ISCHAEMIC HEPATITIS 6 0.0044
86 CENTRAL VENOUS CATHETERISATION 13 0.0043
87 THERAPEUTIC PROCEDURE 6 0.0043
88 BRONCHOSCOPY 1 0.0042
89 CANCER FATIGUE 1 0.0042
90 CORNEAL DEGENERATION 1 0.0041
91 URINE ANALYSIS ABNORMAL 12 0.0040
92 DEVICE ALLERGY 1 0.0040
93 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 1 0.0040
94 PERITONEAL ADHESIONS 1 0.0039
95 DIABETIC RETINAL OEDEMA 2 0.0039
96 NEOVASCULARISATION 1 0.0038
97 LYMPHANGITIS 3 0.0037
98 VASCULAR ACCESS COMPLICATION 3 0.0037
99 INTESTINAL ANASTOMOSIS COMPLICATION 1 0.0037
100 CENTRAL NERVOUS SYSTEM NECROSIS 1 0.0036
101 PROTEINURIA 69 0.0036
102 COLON CANCER RECURRENT 1 0.0036
103 NEUTROPHIL COUNT ABNORMAL 10 0.0035
104 OVARIAN CANCER METASTATIC 3 0.0035
105 ABSCESS DRAINAGE 3 0.0035
106 NON-SMALL CELL LUNG CANCER METASTATIC 3 0.0034
107 CATHETER SITE CELLULITIS 1 0.0034
108 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
109 WEIGHT ABNORMAL 8 0.0033
110 INTERCEPTED MEDICATION ERROR 15 0.0032
111 MACULAR OEDEMA 18 0.0032
112 HOSPICE CARE 31 0.0031
113 BLADDER INJURY 1 0.0031
114 METASTASES TO OVARY 1 0.0031
115 BLOOD PRESSURE MEASUREMENT 2 0.0031
116 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
117 PRODUCT PREPARATION ERROR 62 0.0030
118 INTERCEPTED PRODUCT DISPENSING ERROR 5 0.0030
119 PIK3CA-ACTIVATED MUTATION 1 0.0030
120 MEDICAL PROCEDURE 5 0.0030
121 BLOOD PRESSURE ORTHOSTATIC DECREASED 1 0.0029
122 CARBOHYDRATE ANTIGEN 125 INCREASED 10 0.0029
123 COLOSTOMY CLOSURE 1 0.0029
124 OVARIAN CANCER STAGE III 1 0.0029
125 EPITHELIOID MESOTHELIOMA 1 0.0028
126 SUTURE RELATED COMPLICATION 2 0.0028
127 ACETABULUM FRACTURE 1 0.0027
128 ENTEROVESICAL FISTULA 2 0.0026
129 ALBUMIN URINE PRESENT 1 0.0026
130 PALLIATIVE CARE 4 0.0026
131 PRODUCT ADMINISTRATION INTERRUPTED 20 0.0025
132 PERFORATION 2 0.0025
133 COLON CANCER METASTATIC 4 0.0025
134 ABDOMINAL SYMPTOM 2 0.0025
135 GRANULOCYTE COUNT INCREASED 1 0.0025
136 LAGOPHTHALMOS 1 0.0024
137 MUSCLE STRENGTH ABNORMAL 1 0.0024
138 ORGANIC ERECTILE DYSFUNCTION 1 0.0023
139 BLOOD BILIRUBIN ABNORMAL 3 0.0023
140 COLONIC ABSCESS 2 0.0023
141 OPTICAL COHERENCE TOMOGRAPHY ABNORMAL 2 0.0023
142 TREATMENT DELAYED 4 0.0023
143 PERIPHERAL NERVE INJURY 2 0.0023
144 INCISIONAL DRAINAGE 1 0.0023
145 COLONOSCOPY 5 0.0023
146 MINERAL SUPPLEMENTATION 1 0.0022
147 MUSCLE MASS 1 0.0022
148 LABORATORY TEST ABNORMAL 62 0.0021
149 RETINAL OEDEMA 4 0.0021
150 RED BLOOD CELLS URINE POSITIVE 2 0.0021
151 CARCINOEMBRYONIC ANTIGEN INCREASED 4 0.0021
152 DENTAL OPERATION 5 0.0020
153 FAECAL VOLUME INCREASED 1 0.0019
154 CYST REMOVAL 1 0.0019
155 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1 0.0019
156 MEDICAL DEVICE CHANGE 1 0.0019
157 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
158 CHEMOTHERAPY 7 0.0018
159 NEUROGENIC SHOCK 1 0.0018
160 HEPATOCELLULAR CARCINOMA 14 0.0018
161 TONGUE OEDEMA 7 0.0018
162 BRONCHOSTENOSIS 1 0.0018
163 HYPERTENSIVE URGENCY 1 0.0018
164 PERIRECTAL ABSCESS 2 0.0018
165 BRAIN SCAN ABNORMAL 1 0.0018
166 APNOEIC ATTACK 1 0.0018
167 PRODUCT TEMPERATURE EXCURSION ISSUE 9 0.0017
168 DOSE CALCULATION ERROR 1 0.0017
169 MACULOPATHY 6 0.0017
170 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
171 ENDOSCOPY 1 0.0017
172 DISEASE PROGRESSION 195 0.0016
173 PARACENTESIS 1 0.0016
174 VITRITIS 3 0.0016
175 MEDICAL DEVICE SITE INFECTION 1 0.0016
176 HYPERAESTHESIA TEETH 2 0.0016
177 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
178 ADVERSE EVENT 145 0.0016
179 PHYSICAL DECONDITIONING 4 0.0016
180 ENTEROCOCCUS TEST POSITIVE 1 0.0015
181 NASAL CRUSTING 1 0.0015
182 KLEBSIELLA TEST POSITIVE 1 0.0015
183 ILL-DEFINED DISORDER 92 0.0015
184 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
185 INTENTIONAL DOSE OMISSION 42 0.0015
186 BRAIN CANCER METASTATIC 1 0.0014
187 ANASTOMOTIC LEAK 1 0.0014
188 LARGE INTESTINE PERFORATION 10 0.0014
189 PELVIC FLUID COLLECTION 1 0.0014
190 MYOFASCIAL PAIN SYNDROME 1 0.0014
191 POST HERPETIC NEURALGIA 2 0.0014
192 INVESTIGATION ABNORMAL 2 0.0014
193 DENTAL RESTORATION FAILURE 1 0.0014
194 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
195 PRODUCT PREPARATION ISSUE 9 0.0014
196 BRAIN NEOPLASM MALIGNANT 6 0.0013
197 PLATELET COUNT ABNORMAL 8 0.0013
198 EMERGENCY CARE 4 0.0013
199 OVARIAN CANCER 12 0.0013
200 NEUTROPHIL COUNT DECREASED 53 0.0013
201 NEUROLOGICAL DECOMPENSATION 3 0.0013
202 ENTHESOPATHY 2 0.0013
203 BRONCHIAL CARCINOMA 1 0.0013
204 ENTERITIS 8 0.0012
205 OVARIAN CANCER RECURRENT 2 0.0012
206 HAEMOGLOBIN ABNORMAL 8 0.0012
207 INCISION SITE HAEMORRHAGE 1 0.0012
208 PLATELET COUNT DECREASED 130 0.0012
209 MEAN PLATELET VOLUME DECREASED 1 0.0012
210 GLIOBLASTOMA MULTIFORME 1 0.0012
211 AMAUROSIS 1 0.0012
212 METASTASES TO PERITONEUM 3 0.0012
213 BLOOD PRESSURE INCREASED 181 0.0012
214 NON-INFECTIOUS ENDOPHTHALMITIS 1 0.0012
215 EXPOSURE TO SARS-COV-2 2 0.0012
216 CRANIOFACIAL FRACTURE 1 0.0012
217 CHOROIDAL NEOVASCULARISATION 1 0.0012
218 HEPATIC HAEMORRHAGE 1 0.0012
219 GINGIVAL ERYTHEMA 1 0.0012
220 BLOOD CREATININE ABNORMAL 4 0.0012
221 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
222 FOOD REFUSAL 1 0.0011
223 ARTERIAL STENOSIS 1 0.0011
224 ONYCHOMYCOSIS 5 0.0011
225 LUNG OPACITY 3 0.0011
226 ABDOMINAL SEPSIS 1 0.0011
227 ENTEROCUTANEOUS FISTULA 1 0.0011
228 PRODUCT CONTAMINATION 4 0.0011
229 ABDOMINAL NEOPLASM 1 0.0011
230 WOUND 31 0.0011
231 ARTERIOVENOUS MALFORMATION 1 0.0011
232 THERAPY PARTIAL RESPONDER 17 0.0011
233 ADENOCARCINOMA GASTRIC 1 0.0011
234 TOOTH EXTRACTION 13 0.0010
235 PROCEDURAL HAEMORRHAGE 4 0.0010
236 HYPOGEUSIA 2 0.0010
237 DUODENAL PERFORATION 1 0.0010
238 HYPERTENSION 215 0.0010
239 HEMIANOPIA 1 0.0010
240 UNEVALUABLE EVENT 76 0.0010
241 EAR HAEMORRHAGE 2 0.0010
242 RECTAL CANCER 3 0.0010
243 CAROTID ARTERIOSCLEROSIS 1 0.0010
244 METASTASES TO SKIN 1 0.0010
245 AXILLARY MASS 1 0.0010
246 CEREBRAL ARTERY OCCLUSION 1 0.0009
247 SUSPECTED COVID-19 3 0.0009
248 BLOOD PRESSURE ABNORMAL 18 0.0009
249 FAECES PALE 2 0.0009
250 CALCINOSIS 2 0.0009
251 ADENOCARCINOMA 2 0.0009
252 ACCIDENTAL EXPOSURE TO PRODUCT 89 0.0009
253 HYPERTRANSAMINASAEMIA 6 0.0009
254 SINUS PAIN 2 0.0009
255 ORAL SURGERY 2 0.0009
256 SURGERY 50 0.0009
257 URINARY TRACT OBSTRUCTION 2 0.0008
258 LABILE BLOOD PRESSURE 1 0.0008
259 NON-SMALL CELL LUNG CANCER 4 0.0008
260 SARS-COV-2 TEST POSITIVE 11 0.0008
261 EMBOLISM ARTERIAL 1 0.0008
262 GASTROINTESTINAL TOXICITY 4 0.0008
263 MONOCYTE COUNT DECREASED 1 0.0008
264 INFUSION SITE WARMTH 1 0.0008
265 TOOTH DISORDER 18 0.0008
266 GASTRIC ULCER PERFORATION 1 0.0008
267 GLUCOSE URINE PRESENT 1 0.0008
268 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
269 POOR VENOUS ACCESS 8 0.0008
270 MESOTHELIOMA 1 0.0008
271 FAILURE TO THRIVE 4 0.0008
272 WOUND SECRETION 3 0.0008
273 ADVERSE REACTION 10 0.0008
274 PROTEIN TOTAL INCREASED 2 0.0008
275 GASTRIC PERFORATION 2 0.0007
276 CARBON DIOXIDE INCREASED 1 0.0007
277 EFFUSION 1 0.0007
278 ABSCESS ORAL 1 0.0007
279 BILIARY TRACT DISORDER 1 0.0007
280 GASTROINTESTINAL PERFORATION 3 0.0007
281 MACULE 2 0.0007
282 ONYCHOMADESIS 3 0.0007
283 BRONCHIAL OBSTRUCTION 1 0.0007
284 PERIPHERAL ARTERY OCCLUSION 1 0.0007
285 BLOOD TEST ABNORMAL 10 0.0007
286 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
287 RESPIRATORY SYMPTOM 2 0.0007
288 DYSPNOEA AT REST 2 0.0007
289 PULMONARY PAIN 2 0.0007
290 STRIDOR 2 0.0007
291 COCCYDYNIA 1 0.0007
292 ABDOMINAL ABSCESS 3 0.0007
293 MYASTHENIA GRAVIS CRISIS 1 0.0007
294 ANGIOPLASTY 1 0.0007
295 ODYNOPHAGIA 4 0.0007
296 METABOLIC ENCEPHALOPATHY 2 0.0007
297 HYPOSMIA 1 0.0007
298 INTESTINAL OBSTRUCTION 25 0.0007
299 IMMUNE THROMBOCYTOPENIA 3 0.0007
300 IMMUNE-MEDIATED ADVERSE REACTION 1 0.0007
301 IRON DEFICIENCY ANAEMIA 6 0.0006
302 INFUSION SITE EXTRAVASATION 4 0.0006
303 IRIDOCYCLITIS 2 0.0006
304 INTESTINAL OPERATION 1 0.0006
305 METASTASES TO LIVER 11 0.0006
306 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
307 INTESTINAL PERFORATION 7 0.0006
308 THERAPY INTERRUPTED 44 0.0006
309 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
310 LIVER FUNCTION TEST INCREASED 13 0.0006
311 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
312 TERMINAL STATE 4 0.0006
313 BLOOD MAGNESIUM DECREASED 5 0.0006
314 ASCITES 17 0.0006
315 SKIN NECROSIS 3 0.0006
316 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
317 PAPILLARY THYROID CANCER 1 0.0006
318 EPISTAXIS 43 0.0006
319 OFF LABEL USE 502 0.0006
320 SMALL INTESTINAL OBSTRUCTION 7 0.0006
321 ANAL FISTULA 3 0.0006
322 RETINAL HAEMORRHAGE 4 0.0006
323 ANAL FISSURE 3 0.0006
324 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
325 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 13 0.0006
326 PNEUMOMEDIASTINUM 1 0.0006
327 IMPAIRED HEALING 18 0.0005
328 CAROTID ARTERY OCCLUSION 2 0.0005
329 ESSENTIAL HYPERTENSION 1 0.0005
330 METAMORPHOPSIA 1 0.0005
331 PNEUMOPERITONEUM 1 0.0005
332 WOUND HAEMORRHAGE 2 0.0005
333 CATHETER PLACEMENT 1 0.0005
334 PRODUCT DOSE OMISSION ISSUE 158 0.0005
335 HYDRONEPHROSIS 4 0.0005
336 HEMIPARESIS 9 0.0005
337 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
338 HEPATIC MASS 1 0.0005
339 ARTERIAL THROMBOSIS 1 0.0005
340 REHABILITATION THERAPY 2 0.0005
341 CERVIX CARCINOMA 2 0.0005
342 THROMBOCYTOPENIA 57 0.0005
343 NAIL DISCOLOURATION 2 0.0005
344 ARTERIOSPASM CORONARY 2 0.0005
345 HYPOPHYSITIS 1 0.0005
346 IMMUNE-MEDIATED HEPATITIS 1 0.0005
347 OSTEOLYSIS 1 0.0005
348 TRANSFUSION 5 0.0005
349 EYE CONTUSION 1 0.0005
350 FEBRILE BONE MARROW APLASIA 2 0.0005
351 ABSCESS LIMB 2 0.0005
352 LANGUAGE DISORDER 1 0.0005
353 ENDOMETRIAL CANCER 1 0.0005
354 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1 0.0005
355 APPETITE DISORDER 3 0.0005
356 LARGE INTESTINAL OBSTRUCTION 1 0.0004
357 URINARY TRACT DISORDER 2 0.0004
358 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
359 METASTASES TO MENINGES 1 0.0004
360 BRAIN OPERATION 1 0.0004
361 LICHENOID KERATOSIS 1 0.0004
362 METASTASES TO LUNG 5 0.0004
363 MENTAL STATUS CHANGES 12 0.0004
364 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
365 INGROWING NAIL 1 0.0004
366 BLOOD URINE PRESENT 8 0.0004
367 HAEMATOTOXICITY 4 0.0004
368 MUCOSAL INFLAMMATION 11 0.0004
369 CARDIOGENIC SHOCK 6 0.0004
370 LIMB OPERATION 2 0.0004
371 RASH VESICULAR 2 0.0004
372 ORAL DISORDER 3 0.0004
373 JAUNDICE 11 0.0004
374 CATHETER SITE HAEMORRHAGE 1 0.0004
375 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
376 PLATELET DISORDER 1 0.0004
377 ENDODONTIC PROCEDURE 1 0.0004
378 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
379 ILEOSTOMY 1 0.0004
380 ABDOMINAL INFECTION 1 0.0004
381 CANCER PAIN 1 0.0004
382 AORTIC ARTERIOSCLEROSIS 1 0.0004
383 EJECTION FRACTION DECREASED 6 0.0004
384 CATHETER SITE PAIN 1 0.0004
385 HERNIA REPAIR 1 0.0004
386 WEIGHT FLUCTUATION 4 0.0004
387 GINGIVAL PAIN 3 0.0004
388 BLOOD POTASSIUM ABNORMAL 1 0.0004
389 BLOOD SODIUM INCREASED 1 0.0004
390 ABDOMINAL RIGIDITY 1 0.0004
391 MELAENA 8 0.0004
392 TOOTH FRACTURE 4 0.0004
393 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
394 EMBOLISM 3 0.0004
395 LUNG CONSOLIDATION 1 0.0004
396 DRUG TOLERANCE DECREASED 1 0.0004
397 NECK MASS 1 0.0004
398 RECTAL HAEMORRHAGE 15 0.0003
399 SKIN ULCER 9 0.0003
400 NEUTROPENIA 47 0.0003
401 HYPERTHYROIDISM 5 0.0003
402 STRESS CARDIOMYOPATHY 2 0.0003
403 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
404 BLOOD CREATININE INCREASED 22 0.0003
405 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
406 TOOTHACHE 6 0.0003
407 EMBOLISM VENOUS 1 0.0003
408 ADRENAL INSUFFICIENCY 4 0.0003
409 DERMATITIS ACNEIFORM 2 0.0003
410 PENILE PAIN 1 0.0003
411 MASTICATION DISORDER 1 0.0003
412 DYSAESTHESIA 1 0.0003
413 FIBROSIS 1 0.0003
414 FLANK PAIN 3 0.0003
415 BLOOD CREATININE DECREASED 1 0.0003
416 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
417 ABDOMINAL ADHESIONS 1 0.0003
418 BREAST CANCER RECURRENT 1 0.0003
419 ABSCESS 5 0.0003
420 ATELECTASIS 3 0.0003
421 LIVER ABSCESS 1 0.0003
422 NEUROPATHY PERIPHERAL 29 0.0003
423 TOOTH INFECTION 4 0.0003
424 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
425 PEPTIC ULCER 1 0.0003
426 NEPHRITIS 1 0.0003
427 CEREBRAL HAEMATOMA 1 0.0003
428 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
429 POSTOPERATIVE WOUND INFECTION 2 0.0003
430 TASTE DISORDER 6 0.0003
431 EYELID PTOSIS 3 0.0003
432 UVEITIS 4 0.0003
433 HEPATIC CYST 1 0.0003
434 GINGIVAL BLEEDING 4 0.0003
435 ECCHYMOSIS 2 0.0003
436 LEFT VENTRICULAR FAILURE 1 0.0003
437 ABDOMINAL PAIN 67 0.0003
438 NEUROTOXICITY 5 0.0003
439 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
440 EMBOLIC STROKE 1 0.0003
441 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
442 FIBRIN D DIMER INCREASED 1 0.0003
443 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
444 BREAST CANCER METASTATIC 3 0.0003
445 FACIAL BONES FRACTURE 1 0.0003
446 PELVIC PAIN 5 0.0003
447 OESOPHAGITIS 3 0.0003
448 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
449 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
450 BLINDNESS TRANSIENT 2 0.0003
451 AMYLASE INCREASED 1 0.0003
452 CEREBRAL DISORDER 2 0.0003
453 CARDIAC DYSFUNCTION 1 0.0003
454 COLON CANCER 4 0.0003
455 IMMUNODEFICIENCY 4 0.0003
456 MALNUTRITION 3 0.0003
457 FISTULA 3 0.0003
458 CHROMATURIA 6 0.0003
459 AUTOIMMUNE THYROIDITIS 1 0.0003
460 PARANASAL SINUS DISCOMFORT 1 0.0003
461 MYOCARDIAL ISCHAEMIA 3 0.0003
462 HAEMATURIA 9 0.0003
463 HOSPITALISATION 40 0.0003
464 OESOPHAGEAL ULCER 1 0.0003
465 MUSCULOSKELETAL CHEST PAIN 4 0.0003
466 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
467 HAEMORRHAGIC STROKE 2 0.0003
468 COVID-19 PNEUMONIA 3 0.0003
469 RENAL CYST 2 0.0003
470 MACULAR DEGENERATION 3 0.0003
471 HAEMOPTYSIS 7 0.0003
472 POLYNEUROPATHY 3 0.0003
473 BLOOD DISORDER 2 0.0002
474 HAEMORRHAGE 26 0.0002
475 STENT PLACEMENT 2 0.0002
476 FUNGAL SKIN INFECTION 1 0.0002
477 PRODUCT ADMINISTRATION ERROR 5 0.0002
478 CYTOPENIA 3 0.0002
479 MULTIPLE FRACTURES 4 0.0002
480 INFUSION RELATED REACTION 16 0.0002
481 BRAIN OEDEMA 3 0.0002
482 INFUSION SITE ERYTHEMA 2 0.0002
483 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
484 INFUSION SITE PAIN 3 0.0002
485 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
486 METASTATIC NEOPLASM 1 0.0002
487 MONOPLEGIA 1 0.0002
488 PRODUCT DISPENSING ERROR 5 0.0002
489 PRODUCT COMMUNICATION ISSUE 2 0.0002
490 GINGIVAL SWELLING 1 0.0002
491 BLOOD CREATINE INCREASED 1 0.0002
492 TRANSAMINASES INCREASED 5 0.0002
493 HEPATOTOXICITY 5 0.0002
494 BLOOD BILIRUBIN INCREASED 6 0.0002
495 LEUKOCYTOSIS 4 0.0002
496 TACHYPNOEA 3 0.0002
497 PNEUMONITIS 6 0.0002
498 HAEMOGLOBIN INCREASED 1 0.0002
499 MALAISE 96 0.0002
500 DISEASE COMPLICATION 1 0.0002
501 CELLULITIS 11 0.0002
502 BRAIN NEOPLASM 2 0.0002
503 RETINAL DETACHMENT 2 0.0002
504 EYE OPERATION 1 0.0002
505 DIVERTICULITIS 6 0.0002
506 LOCALISED OEDEMA 1 0.0002
507 AGRANULOCYTOSIS 4 0.0002
508 ERYTHEMA MULTIFORME 2 0.0002
509 PERFORMANCE STATUS DECREASED 1 0.0002
510 DIARRHOEA HAEMORRHAGIC 2 0.0002
511 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
512 ADVERSE DRUG REACTION 19 0.0002
513 EYE INFLAMMATION 2 0.0002
514 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
515 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
516 HUMERUS FRACTURE 1 0.0002
517 ENTEROCOCCAL INFECTION 1 0.0002
518 HERNIA 4 0.0002
519 GUILLAIN-BARRE SYNDROME 1 0.0002
520 THROMBOTIC MICROANGIOPATHY 2 0.0002
521 HAEMOGLOBIN DECREASED 21 0.0002
522 INCORRECT DOSAGE ADMINISTERED 1 0.0002
523 VITREOUS FLOATERS 2 0.0002
524 THERAPY CHANGE 2 0.0002
525 BODY TEMPERATURE DECREASED 2 0.0002
526 BREATH SOUNDS ABNORMAL 1 0.0002
527 HYPERVOLAEMIA 1 0.0002
528 LIGAMENT SPRAIN 2 0.0002
529 PULMONARY MASS 3 0.0002
530 ABDOMINAL TENDERNESS 1 0.0002
531 HAEMORRHAGE INTRACRANIAL 3 0.0002
532 PULMONARY EMBOLISM 19 0.0002
533 FLUID INTAKE REDUCED 1 0.0002
534 HAEMATOCHEZIA 11 0.0002
535 HYPONATRAEMIA 11 0.0002
536 ENDOCARDITIS 1 0.0002
537 DEHYDRATION 26 0.0002
538 ASTHENIA 73 0.0002
539 ANAPHYLACTIC SHOCK 5 0.0002
540 PERITONITIS 4 0.0002
541 PARTIAL SEIZURES 1 0.0002
542 INCONTINENCE 2 0.0002
543 PNEUMOTHORAX 3 0.0002
544 RENAL PAIN 2 0.0002
545 NYSTAGMUS 1 0.0002
546 DYSPHONIA 11 0.0002
547 DECREASED APPETITE 43 0.0002
548 BEHAVIOUR DISORDER 1 0.0002
549 BLOOD POTASSIUM INCREASED 3 0.0002
550 DEEP VEIN THROMBOSIS 12 0.0002
551 COLITIS 7 0.0002
552 ILLNESS 19 0.0002
553 LIMB INJURY 5 0.0002
554 SKIN LACERATION 2 0.0002
555 METASTASES TO BONE 3 0.0002
556 JAW DISORDER 1 0.0002
557 INFECTION 26 0.0002
558 HEART RATE ABNORMAL 1 0.0002
559 GASTROINTESTINAL DISORDER 16 0.0002
560 ACUTE PULMONARY OEDEMA 1 0.0002
561 BLOOD CALCIUM DECREASED 2 0.0002
562 EYE INFECTION 2 0.0002
563 COLECTOMY 1 0.0002
564 PERONEAL NERVE PALSY 1 0.0002
565 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
566 NEUROLOGICAL SYMPTOM 1 0.0002
567 RED BLOOD CELL COUNT DECREASED 5 0.0002
568 VOMITING 82 0.0002
569 NEOPLASM 2 0.0002
570 COGNITIVE DISORDER 8 0.0002
571 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
572 CHILLS 20 0.0002
573 BRADYCARDIA 9 0.0002
574 ISCHAEMIC STROKE 3 0.0002
575 CARDIAC PACEMAKER INSERTION 1 0.0002
576 ACCIDENT 2 0.0002
577 FATIGUE 130 0.0002
578 WRIST FRACTURE 2 0.0002
579 HYPERGLYCAEMIA 6 0.0002
580 BONE DISORDER 3 0.0002
581 SEIZURE 19 0.0002
582 INGUINAL HERNIA 1 0.0002
583 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
584 WEIGHT DECREASED 45 0.0002
585 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 29 0.0002
586 HEPATIC CIRRHOSIS 3 0.0002
587 NASAL DRYNESS 1 0.0002
588 INFUSION SITE SWELLING 1 0.0002
589 FOOT FRACTURE 3 0.0002
590 LIVER DISORDER 7 0.0002
591 TACHYCARDIA 14 0.0002
592 HERPES ZOSTER 9 0.0002
593 HYPOTHYROIDISM 5 0.0002
594 CHEST DISCOMFORT 16 0.0002
595 CHOLESTASIS 3 0.0002
596 POST PROCEDURAL COMPLICATION 3 0.0002
597 PYREXIA 54 0.0002
598 THERAPY CESSATION 8 0.0002
599 THERAPY NON-RESPONDER 7 0.0002
600 COVID-19 27 0.0002
601 DIARRHOEA 99 0.0002
602 URINARY TRACT INFECTION 26 0.0002
603 ORAL CANDIDIASIS 2 0.0002
604 IMMUNE SYSTEM DISORDER 2 0.0002
605 CATARACT 9 0.0002
606 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
607 MENINGITIS 1 0.0001
608 FEEDING DISORDER 3 0.0001
609 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
610 CONSTIPATION 32 0.0001
611 INFARCTION 1 0.0001
612 NEPHROTIC SYNDROME 1 0.0001
613 RIB FRACTURE 3 0.0001
614 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
615 LYMPHOEDEMA 1 0.0001
616 NEOPLASM PROGRESSION 5 0.0001
617 HYPOMAGNESAEMIA 2 0.0001
618 CARPAL TUNNEL SYNDROME 2 0.0001
619 OXYGEN SATURATION DECREASED 8 0.0001
620 DEVICE OCCLUSION 2 0.0001
621 PAIN IN JAW 4 0.0001
622 BRONCHOSPASM 2 0.0001
623 LEUKOPENIA 7 0.0001
624 PANIC REACTION 1 0.0001
625 FAECES DISCOLOURED 3 0.0001
626 SEPTIC SHOCK 6 0.0001
627 INJECTION SITE HAEMATOMA 2 0.0001
628 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
629 VISUAL IMPAIRMENT 17 0.0001
630 NAUSEA 108 0.0001
631 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
632 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
633 GLOSSODYNIA 3 0.0001
634 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
635 DEVICE RELATED INFECTION 2 0.0001
636 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
637 APHTHOUS ULCER 1 0.0001
638 BRAIN FOG 2 0.0001
639 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
640 CYANOSIS 2 0.0001
641 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
642 DYSPHAGIA 12 0.0001
643 DISORIENTATION 5 0.0001
644 BLOOD ALBUMIN DECREASED 1 0.0001
645 COLORECTAL CANCER 6 0.0001
646 FRUSTRATION TOLERANCE DECREASED 1 0.0001
647 DECUBITUS ULCER 1 0.0001
648 ASPHYXIA 1 0.0001
649 ENCEPHALOPATHY 3 0.0001
650 HICCUPS 1 0.0001
651 HYPERAESTHESIA 1 0.0001
652 ACUTE CORONARY SYNDROME 1 0.0001
653 FEBRILE NEUTROPENIA 8 0.0001
654 ANAEMIA 23 0.0001
655 BLOOD UREA INCREASED 2 0.0001
656 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
657 CANDIDA INFECTION 2 0.0001
658 HYPOPHAGIA 3 0.0001
659 FALL 39 0.0001
660 HAEMATOMA 3 0.0001
661 PLEURAL EFFUSION 7 0.0001
662 ABDOMINAL DISTENSION 12 0.0001
663 DYSPNOEA 65 0.0001
664 GROIN PAIN 1 0.0001
665 CEREBROVASCULAR ACCIDENT 19 0.0001
666 CARDIOTOXICITY 1 0.0001
667 FACIAL PAIN 1 0.0001
668 CEREBRAL HAEMORRHAGE 4 0.0001
669 GASTROINTESTINAL INFECTION 1 0.0001
670 ANAL INCONTINENCE 1 0.0001
671 OSTEOMYELITIS 2 0.0001
672 PALLOR 3 0.0001
673 SKIN LESION 3 0.0001
674 RESPIRATORY DISTRESS 3 0.0001
675 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
676 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
677 HYPOKALAEMIA 5 0.0001
678 FLUSHING 11 0.0001
679 PROCEDURAL PAIN 3 0.0001
680 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
681 CHEST PAIN 20 0.0001
682 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
683 SEPSIS 12 0.0001
684 HEPATIC FUNCTION ABNORMAL 4 0.0001
685 HEPATIC ENCEPHALOPATHY 1 0.0001
686 NEPHROPATHY 1 0.0001
687 DYSPNOEA EXERTIONAL 4 0.0001
688 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
689 HYPOCALCAEMIA 2 0.0001
690 FRACTURE 2 0.0001
691 FEELING JITTERY 2 0.0001
692 INCREASED APPETITE 2 0.0001
693 ACUTE RESPIRATORY FAILURE 2 0.0001
694 DRUG INTOLERANCE 10 0.0001
695 COUGH 29 0.0001
696 DIZZINESS POSTURAL 1 0.0001
697 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
698 SKIN FISSURES 2 0.0001
699 PHARYNGEAL SWELLING 1 0.0001
700 KIDNEY INFECTION 2 0.0001
701 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
702 ACUTE MYOCARDIAL INFARCTION 3 0.0001
703 HAEMATOCRIT DECREASED 2 0.0001
704 UPPER LIMB FRACTURE 2 0.0001
705 BLOOD POTASSIUM DECREASED 3 0.0001
706 CARDIAC FAILURE 8 0.0001
707 APHASIA 3 0.0001
708 EMPHYSEMA 1 0.0001
709 PERITONITIS BACTERIAL 1 0.0001
710 STOMATITIS 6 0.0001
711 HYPOTHERMIA 1 0.0001
712 DEATH 85 0.0001
713 DRY THROAT 1 0.0001
714 DISCOMFORT 6 0.0001
715 INJURY ASSOCIATED WITH DEVICE 2 0.0001
716 MOTOR DYSFUNCTION 1 0.0001
717 MOBILITY DECREASED 7 0.0001
718 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
719 OROPHARYNGEAL PAIN 9 0.0001
720 INFLUENZA LIKE ILLNESS 8 0.0001
721 ABDOMINAL PAIN UPPER 20 0.0001
722 HYPERBILIRUBINAEMIA 1 0.0001
723 PETECHIAE 1 0.0001
724 ROAD TRAFFIC ACCIDENT 4 0.0001
725 DERMATITIS 2 0.0001
726 MUSCULOSKELETAL PAIN 5 0.0001
727 FULL BLOOD COUNT ABNORMAL 1 0.0001
728 RETCHING 2 0.0001
729 HYPERSENSITIVITY 17 0.0001
730 EYE DISORDER 3 0.0001
731 RASH MACULO-PAPULAR 2 0.0001
732 HYPERTENSIVE CRISIS 1 0.0001
733 NEPHROPATHY TOXIC 1 0.0001
734 MICTURITION URGENCY 1 0.0001
735 INTERNAL HAEMORRHAGE 1 0.0001
736 MYOCARDITIS 1 0.0001
737 NASAL CONGESTION 5 0.0001
738 LYMPHADENOPATHY 3 0.0001
739 ARRHYTHMIA 4 0.0001
740 ATAXIA 1 0.0001
741 PRODUCT PRESCRIBING ERROR 2 0.0001
742 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
743 HEPATITIS C 1 0.0001
744 NOCTURIA 1 0.0001
745 RESPIRATORY FAILURE 6 0.0001
746 PRESYNCOPE 2 0.0001
747 NEURALGIA 2 0.0001
748 ARTHRALGIA 34 0.0001
749 LUNG DISORDER 4 0.0001
750 FEELING HOT 5 0.0001
751 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
752 OSTEONECROSIS OF JAW 2 0.0001
753 HEART RATE INCREASED 8 0.0001
754 DYSARTHRIA 3 0.0001
755 DERMATITIS ALLERGIC 1 0.0001
756 CARDIOVASCULAR DISORDER 2 0.0001
757 HEPATIC CYTOLYSIS 1 0.0001
758 INTRAOCULAR PRESSURE INCREASED 1 0.0001
759 GENITAL HAEMORRHAGE 1 0.0001
760 UNRESPONSIVE TO STIMULI 2 0.0001
761 BACK PAIN 18 0.0001
762 DEAFNESS 2 0.0001
763 SPEECH DISORDER 4 0.0001
764 BEDRIDDEN 1 0.0001
765 PANCREATITIS 4 0.0001
766 EYE HAEMORRHAGE 1 0.0001
767 HYPOTENSION 15 0.0001
768 THROAT TIGHTNESS 2 0.0001
769 RASH PRURITIC 4 0.0001
770 OEDEMA 4 0.0001
771 HEPATIC ENZYME INCREASED 5 0.0001
772 AKATHISIA 1 0.0001
773 LUNG NEOPLASM MALIGNANT 3 0.0001
774 CORONARY ARTERY OCCLUSION 1 0.0001
775 CARDIAC ARREST 6 0.0001
776 ANAPHYLACTIC REACTION 4 0.0001
777 ORAL DISCOMFORT 1 0.0001
778 APHONIA 1 0.0001
779 NECK PAIN 4 0.0001
780 PAIN IN EXTREMITY 21 0.0001
781 BLISTER 4 0.0001
782 SLEEP DISORDER 5 0.0001
783 NASOPHARYNGITIS 13 0.0001
784 HEADACHE 44 0.0001
785 HYPERSOMNIA 2 0.0001
786 PARAESTHESIA ORAL 1 0.0001
787 VAGINAL HAEMORRHAGE 3 0.0001
788 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
789 LIVER FUNCTION TEST ABNORMAL 2 0.0001
790 CONFUSIONAL STATE 11 0.0001
791 CARDIOMYOPATHY 1 0.0001
792 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
793 DRY SKIN 9 0.0001
794 THROAT IRRITATION 3 0.0001
795 RESPIRATORY DISORDER 2 0.0001
796 DEVICE FAILURE 1 0.0001
797 OEDEMA PERIPHERAL 8 0.0001
798 VERTIGO 4 0.0001
799 DEVICE ADHESION ISSUE 1 0.0001
800 PNEUMONIA 21 0.0001
801 LYMPHOMA 1 0.0001
802 CARDIAC DISORDER 6 0.0001
803 BASAL CELL CARCINOMA 1 0.0001
804 NERVOUS SYSTEM DISORDER 2 0.0001
805 DRUG-INDUCED LIVER INJURY 2 0.0001
806 ARTHRITIS 5 0.0001
807 HEAD INJURY 2 0.0001
808 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
809 CYSTITIS 2 0.0001
810 INFLUENZA 7 0.0001
811 OBESITY 1 0.0001
812 METABOLIC ACIDOSIS 2 0.0001
813 MOVEMENT DISORDER 2 0.0001
814 HYPERHIDROSIS 8 0.0001
815 NIGHT SWEATS 2 0.0001
816 PAIN 38 0.0001
817 DRY MOUTH 5 0.0001
818 MUSCULAR WEAKNESS 7 0.0001
819 AMNESIA 4 0.0001
820 CHOLELITHIASIS 2 0.0001
821 STAPHYLOCOCCAL INFECTION 2 0.0001
822 PHOTOSENSITIVITY REACTION 1 0.0001
823 VIRAL INFECTION 2 0.0001
824 COAGULOPATHY 1 0.0001
825 FUNGAL INFECTION 2 0.0001
826 SKIN DISORDER 2 0.0001
827 URINARY RETENTION 2 0.0001
828 NEOPLASM MALIGNANT 4 0.0001
829 CIRCULATORY COLLAPSE 1 0.0001
830 ERYTHEMA 12 0.0001
831 GASTRIC DISORDER 2 0.0001
832 VISION BLURRED 8 0.0001
833 INFLAMMATION 3 0.0001
834 ORTHOSTATIC HYPOTENSION 1 0.0001
835 RASH 25 0.0001
836 INTENTIONAL PRODUCT MISUSE 5 0.0001
837 AMENORRHOEA 1 0.0001
838 HEART RATE DECREASED 2 0.0001
839 INJURY 4 0.0001
840 HYPOXIA 2 0.0001
841 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
842 LYMPHOCYTE COUNT DECREASED 1 0.0001
843 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
844 HEAD DISCOMFORT 1 0.0001
845 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
846 MYELOSUPPRESSION 2 0.0001
847 GASTROENTERITIS VIRAL 1 0.0001
848 DYSURIA 2 0.0001
849 DIZZINESS 27 0.0001
850 PANCYTOPENIA 3 0.0001
851 HYPOAESTHESIA 8 0.0001
852 PHOTOPHOBIA 1 0.0001
853 BLOOD SODIUM DECREASED 1 0.0001
854 FLATULENCE 3 0.0001
855 RENAL FAILURE 7 0.0001
856 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
857 LETHARGY 3 0.0001
858 GLAUCOMA 1 0.0001
859 ERUCTATION 1 0.0001
860 ATRIAL FIBRILLATION 5 0.0001
861 HAEMORRHOIDS 1 0.0001
862 CHOKING 1 0.0001
863 ORAL HERPES 1 0.0001
864 BONE PAIN 3 0.0001
865 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
866 THROMBOSIS 4 0.0000
867 FULL BLOOD COUNT DECREASED 1 0.0000
868 BONE MARROW FAILURE 1 0.0000
869 BLINDNESS 2 0.0000
870 ABDOMINAL DISCOMFORT 8 0.0000
871 HALLUCINATION, VISUAL 1 0.0000
872 RHINORRHOEA 3 0.0000
873 BALANCE DISORDER 4 0.0000
874 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
875 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
876 SWELLING FACE 3 0.0000
877 ANXIETY 13 0.0000
878 PERIPHERAL SWELLING 7 0.0000
879 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
880 SOMNOLENCE 9 0.0000
881 PULMONARY OEDEMA 2 0.0000
882 ORAL PAIN 1 0.0000
883 DEVICE ISSUE 4 0.0000
884 PRURITUS 17 0.0000
885 APPLICATION SITE PRURITUS 1 0.0000
886 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
887 NEPHROLITHIASIS 2 0.0000
888 SWELLING 4 0.0000
889 BLOOD GLUCOSE INCREASED 8 0.0000
890 OCULAR HYPERAEMIA 2 0.0000
891 DISEASE RECURRENCE 2 0.0000
892 PRODUCTIVE COUGH 2 0.0000
893 GAIT DISTURBANCE 8 0.0000
894 BLOOD PRESSURE FLUCTUATION 1 0.0000
895 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
896 CONTUSION 4 0.0000
897 LOCALISED INFECTION 1 0.0000
898 MYALGIA 7 0.0000
899 CEREBRAL INFARCTION 1 0.0000
900 LIVER INJURY 1 0.0000
901 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
902 PNEUMONIA ASPIRATION 1 0.0000
903 ABDOMINAL PAIN LOWER 1 0.0000
904 CHRONIC KIDNEY DISEASE 3 0.0000
905 GASTRIC CANCER 1 0.0000
906 HAEMATEMESIS 1 0.0000
907 DIABETES MELLITUS 3 0.0000
908 HEPATITIS 1 0.0000
909 ERECTILE DYSFUNCTION 1 0.0000
910 DIPLOPIA 1 0.0000
911 DRUG DOSE OMISSION BY DEVICE 3 0.0000
912 JOINT STIFFNESS 1 0.0000
913 GASTRITIS 1 0.0000
914 DRUG INTERACTION 6 0.0000
915 INJECTION SITE HAEMORRHAGE 3 0.0000
916 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
917 FEAR 1 0.0000
918 DISTURBANCE IN ATTENTION 2 0.0000
919 FREQUENT BOWEL MOVEMENTS 1 0.0000
920 ARTHROPATHY 2 0.0000
921 RENAL IMPAIRMENT 3 0.0000
922 TOXICITY TO VARIOUS AGENTS 6 0.0000
923 SKIN EXFOLIATION 3 0.0000
924 EYE PAIN 2 0.0000
925 DEPRESSION 8 0.0000
926 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
927 INCORRECT DOSE ADMINISTERED 8 0.0000
928 ANGINA PECTORIS 1 0.0000
929 PRODUCT SUBSTITUTION ISSUE 2 0.0000
930 MYOCARDIAL INFARCTION 6 0.0000
931 DYSSTASIA 1 0.0000
932 FEELING ABNORMAL 8 0.0000
933 HEPATIC FAILURE 1 0.0000
934 LACRIMATION INCREASED 1 0.0000
935 CORONARY ARTERY DISEASE 1 0.0000
936 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
937 EMOTIONAL DISORDER 1 0.0000
938 PRODUCT USE ISSUE 6 0.0000
939 PARAESTHESIA 5 0.0000
940 MIGRAINE 3 0.0000
941 WEIGHT INCREASED 7 0.0000
942 LOSS OF CONSCIOUSNESS 4 0.0000
943 HIP FRACTURE 1 0.0000
944 DYSPEPSIA 3 0.0000
945 EXPIRED PRODUCT ADMINISTERED 1 0.0000
946 LIP SWELLING 1 0.0000
947 GAIT INABILITY 1 0.0000
948 ANGER 1 0.0000
949 MEMORY IMPAIRMENT 4 0.0000
950 INJECTION SITE REACTION 2 0.0000
951 DRUG INEFFECTIVE 38 0.0000
952 BURNING SENSATION 2 0.0000
953 HYPERKALAEMIA 1 0.0000
954 CRYING 1 0.0000
955 C-REACTIVE PROTEIN INCREASED 1 0.0000
956 DYSGEUSIA 2 0.0000
957 EYE SWELLING 1 0.0000
958 HOT FLUSH 2 0.0000
959 CONDITION AGGRAVATED 8 0.0000
960 ACUTE KIDNEY INJURY 4 0.0000
961 PALPITATIONS 3 0.0000
962 CARDIAC FAILURE CONGESTIVE 2 0.0000
963 EXTRA DOSE ADMINISTERED 1 0.0000
964 DEVICE BREAKAGE 1 0.0000
965 TREATMENT FAILURE 2 0.0000
966 CARDIO-RESPIRATORY ARREST 1 0.0000
967 MENTAL DISORDER 1 0.0000
968 INSOMNIA 6 0.0000
969 BLOOD CHOLESTEROL INCREASED 1 0.0000
970 COMA 1 0.0000
971 INTERSTITIAL LUNG DISEASE 1 0.0000
972 SYNCOPE 2 0.0000
973 FLUID RETENTION 1 0.0000
974 SINUSITIS 2 0.0000
975 NERVOUSNESS 1 0.0000
976 DEPRESSED MOOD 1 0.0000
977 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
978 TREMOR 3 0.0000
979 EYE IRRITATION 1 0.0000
980 IRRITABILITY 1 0.0000
981 NO ADVERSE EVENT 3 0.0000
982 ALOPECIA 3 0.0000
983 DEVICE DIFFICULT TO USE 1 0.0000
984 DEVICE MALFUNCTION 1 0.0000
985 AGITATION 1 0.0000
986 BRONCHITIS 1 0.0000
987 ACNE 1 0.0000
988 INJECTION SITE SWELLING 1 0.0000
989 MUSCULOSKELETAL STIFFNESS 1 0.0000
990 BREAST CANCER 1 0.0000
991 JOINT SWELLING 1 0.0000
992 MUSCLE SPASMS 1 0.0000
993 INJECTION SITE PAIN 1 0.0000